ENTPD1 and esophageal squamous cell carcinoma: Three of these genes belong to the B7 family of ligands, and two of these are adenosine receptors, in addition to adenosine-producing ENTPD1. These findings indicate that an improved response is possible for ESCC by utilizing checkpoint inhibition and new combination targets in conjunction with anti-PD-1.